UBS analyst Joseph Spak lowered the firm’s price target on Amphenol (APH) to $78 from $90 and keeps a Buy rating on the shares. The macro environment and tariffs will impact connector earnings, but UBS sees a track record of passing on costs, history of resiliency, and better mid-term stories, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
